PRT1419

News alerts, weekly reports and conference planners

Company:

Prelude Therap

Drug class:

MCL1 inhibitor

Related drugs:

SMARCA4 deletion	Lung Cancer	SMARCA4 deletion	Lung Cancer	PRT1419 + PRT3789 Sensitive: D – Preclinical PRT1419 + PRT3789 Sensitive : D	PRT1419 + PRT3789 Sensitive: D – Preclinical PRT1419 + PRT3789 Sensitive : D
PBRM1 mutation	Renal Cell Carcinoma	PBRM1 mutation	Renal Cell Carcinoma	PRT1419 Sensitive: D – Preclinical PRT1419 Sensitive : D	PRT1419 Sensitive: D – Preclinical PRT1419 Sensitive : D

Associations
(2)